We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMGBU
5151
DELISTED
RMG Acquisition Corp. II Unit
RMGBU
$2K ﹤0.01%
+151
New +$1.58K
LIVK
5152
DELISTED
LIV Capital Acquisition Corp. Class A Ordinary Shares
LIVK
$2K ﹤0.01%
189
DGNR.U
5153
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$2K ﹤0.01%
195
-484
-71% -$5.07K
SVACU
5154
DELISTED
Starboard Value Acquisition Corp. Unit
SVACU
$2K ﹤0.01%
192
+5
+3% +$51
CAP.U
5155
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
$2K ﹤0.01%
151
-20
-12% -$207
RAACU
5156
DELISTED
Revolution Acceleration Acquisition Corp Unit
RAACU
$2K ﹤0.01%
209
-7
-3% -$74
AONE.U
5157
DELISTED
one Units, each consisting of one Class A ordinary share, and one-fourth of a Warrant to acquire one
AONE.U
$2K ﹤0.01%
+230
New +$2.46K
ALUS.U
5158
DELISTED
Alussa Energy Acquisition Corp
ALUS.U
$2K ﹤0.01%
180
-260
-59% -$2.85K
CEMI
5159
DELISTED
Chembio diagnostics, Inc.
CEMI
$2K ﹤0.01%
677
-3,314
-83% -$11.6K
MBT
5160
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$2K ﹤0.01%
+198
New +$1.76K
ABCL icon
5161
AbCellera Biologics
ABCL
$2.12B
$1K ﹤0.01%
68
-3,396
-98% -$93.6K
ADIL
5162
Adial Pharmaceuticals
ADIL
$8.71M
$1K ﹤0.01%
1
-1
-50% -$1.52K
ADMA icon
5163
ADMA Biologics
ADMA
$2.22B
$1K ﹤0.01%
533
-25,387
-98% -$44.7K
AMBO
5164
Ambow Education Holding
AMBO
$5.15M
$1K ﹤0.01%
30
ANEB
5165
DELISTED
Anebulo Pharmaceuticals
ANEB
$1K ﹤0.01%
+158
New +$1.18K
APT icon
5166
Alpha Pro Tech
APT
$53.1M
$1K ﹤0.01%
100
-1,291
-93% -$11.3K
ASLE icon
5167
AerSale
ASLE
$279M
$1K ﹤0.01%
+68
New +$831
AUDC icon
5168
AudioCodes
AUDC
$253M
$1K ﹤0.01%
41
-1,613
-98% -$51.5K
AVAL icon
5169
Grupo Aval
AVAL
$6.01B
$1K ﹤0.01%
+159
New +$946
FABC
5170
Fabric.AI Inc
FABC
$18.4M
$1K ﹤0.01%
2
-229
-99% -$151K
BB icon
5171
BlackBerry
BB
$5.26B
$1K ﹤0.01%
44
-47,698
-100% -$500K
BBGI icon
5172
Beasley Broadcasting Group
BBGI
$40M
$1K ﹤0.01%
22
-60
-73% -$3.35K
BMEA icon
5173
Biomea Fusion
BMEA
$91.3M
$1K ﹤0.01%
+61
New +$1.08K
BON
5174
Bon Natural Life
BON
$8.7M
$1K ﹤0.01%
+1
New +$1.82K
BSBK icon
5175
Bogota Financial
BSBK
$111M
$1K ﹤0.01%
100
-1,428
-93% -$14.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.